Pharmacotherapy for insomnia.

Syed H Tariq, Shailaja Pulisetty

Review Clinics in geriatric medicine 2008 53 atıf

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D18035234'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

Çalışma Türü: Review
Popülasyon: None

Müdahale: Pharmacotherapy for insomnia. None
Karşılaştırıcı: None
Birincil Sonuç: Pharmacotherapy for insomnia.
Etki Yönü: Mixed
Yanlılık Riski: Unclear

Abstract

Hypnotics are commonly use in the treatment of insomnia, and hypnotic use among older adults is more prevalent than with younger adults. Unfortunately, the use of hypnotics is not well studied in the ever-growing geriatric population and the magnitude of the medication benefit is usually not impressive. Insomnia in older adults is usually treated with benzodiazepines, nonbenzodiazepines, and other agents, such as trazodone, valerian, and melatonin. Using appropriately selected agents and therapy initiated with a low dose and careful monitoring of the patient could minimize common unwanted side effects.

Kısaca

Using appropriately selected agents and therapy initiated with a low dose and careful monitoring of the patient could minimize common unwanted side effects.

Used In Evidence Reviews

A Melatonin için Uykusuzluk

A Valerian Kökü için Uykusuzluk

Pharmacotherapy for insomnia.

Embed This Widget

Study Design

Abstract

Kısaca

Used In Evidence Reviews

Similar Papers

European guideline for the diagnosis and treatment of insomnia.

Circadian typology: a comprehensive review.

Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Regulation of terminal differentiation of cultured human keratinocytes by vitamin A.

Role of melatonin in the regulation of human circadian rhythms and sleep.